SHPH: Shuttle Pharmaceuticals Holdings, Inc. Stock

by  •  • Comments Off on SHPH: Shuttle Pharmaceuticals Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1.60
Enterprise Value ($M) 0.56
Book Value ($M) 0.71
Book Value / Share 0.11
Price / Book 2.26
NCAV ($M) 0.41
NCAV / Share 0.07
Price / NCAV 3.87

Profitability (mra)
Return on Invested Capital (ROIC) -4.86
Return on Assets (ROA) -1.92
Return on Equity (ROE) -3.31

Liquidity (mrq)
Quick Ratio 1.44
Current Ratio 1.44

Balance Sheet (mrq) ($M)
Current Assets 2.21
Assets 2.51
Liabilities 1.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -7.70
Net Income -9.14

Cash Flow Statement (mra) ($M)
Cash From Operations -7.33
Cash from Investing 2.92
Cash from Financing 3.76

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Armistice Capital, Llc 7.51

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-09-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-09-04 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-09-04 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 135,420 367,954 36.80
2025-04-16 201,080 613,058 32.80
2025-04-15 239,120 1,045,791 22.86
2025-04-14 416,119 1,267,812 32.82

(click for more detail)

Similar Companies
SBFM – Sunshine Biopharma, Inc. SCLX – Scilex Holding Company
SGMO – Sangamo Therapeutics, Inc. SILO – Silo Pharma, Inc.
SLGL – Sol-Gel Technologies Ltd.


Financial data and stock pages provided by
Fintel.io